Publications by authors named "Colin Hislop"

Claim this Profile
E
Early Treatment with Pegylated Interferon Lambda for Covid-19.
Gilmar Reis, Eduardo A S Moreira Silva, Daniela C Medeiros Silva, Lehana Thabane, Vitoria H S Campos, Colin Hislop

N Engl J Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial.
Jordan J Feld, Christopher Kandel, Mia J Biondi, Robert A Kozak, Muhammad Atif Zahoor, Colin Hislop

Lancet Respir Med· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial.
Prasanna Jagannathan, Jason R Andrews, Hector Bonilla, Haley Hedlin, Karen B Jacobson, Colin Hislop

Nat Commun· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blisibimod for treatment of systemic lupus erythematosus: with trials you become wiser.
Morton A Scheinberg, Colin M Hislop, Renee S Martin

Expert Opin Biol Ther· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disappearance of cryoproteins in the sera of a patient with SLE after treatment with blisibimod, a novel subcutaneous anti-B cell therapy.
Andrea Pimentel Fonseca Golmia, Renee Martin, Colin Hislop, Morton Scheinberg

Rheumatology (Oxford)· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of secretory phospholipase A(2) in patients with acute coronary syndromes: rationale and design of the vascular inflammation suppression to treat acute coronary syndrome for 16 weeks (VISTA-16) trial.
Stephen J Nicholls, Matthew A Cavender, John J P Kastelein, Gregory Schwartz, David D Waters, Colin Hislop

Cardiovasc Drugs Ther· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-inflammatory effects of varespladib methyl in diabetic patients with acute coronary syndrome.
Robert S Rosenson, Heather Fraser, Michael A Goulder, Colin Hislop

Cardiovasc Drugs Ther· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial of an inhibitor of secretory phospholipase A2 on atherogenic lipoprotein subclasses in statin-treated patients with coronary heart disease.
Robert S Rosenson, Michael Elliott, Yuri Stasiv, Colin Hislop,

Eur Heart J· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Varespladib methyl in cardiovascular disease.
Robert S Rosenson, Heather Fraser, Joaquim Trias, Colin Hislop

Expert Opin Investig Drugs· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of varespladib methyl on biomarkers and major cardiovascular events in acute coronary syndrome patients.
Robert S Rosenson, Colin Hislop, Michael Elliott, Yuri Stasiv, Michael Goulder

J Am Coll Cardiol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of 1-H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A2 (PLASMA study): a phase II double-blind, randomised, placebo-controlled trial.
Robert S Rosenson, Colin Hislop, Daniel McConnell, Michael Elliott, Yuri Stasiv

Lancet· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Varespladib (A-002), a secretory phospholipase A2 inhibitor, reduces atherosclerosis and aneurysm formation in ApoE-/- mice.
Heather Fraser, Colin Hislop, Robert M Christie, Heather L Rick, Charles A Reidy

J Cardiovasc Pharmacol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis